• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞生长因子/散射因子(HGF/SF)及其受体c-Met酪氨酸激酶的发育作用

Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase.

作者信息

Birchmeier C, Gherardi E

机构信息

Dept of Medical Genetics, Max-Delbrück-Centrum for Molecular Medicine, Berlin, Germany.

出版信息

Trends Cell Biol. 1998 Oct;8(10):404-10. doi: 10.1016/s0962-8924(98)01359-2.

DOI:10.1016/s0962-8924(98)01359-2
PMID:9789329
Abstract

A number of developmental processes that involve cell migration, growth or morphogenesis depend on extracellular signals. A molecule that provides such signals, known as hepatocyte growth factor/scatter factor (HGF/SF), has attracted considerable interest in recent years because of its distinct structure, mechanism of activation and important roles throughout embryogenesis. This review discusses the main features of HGF/SF and its receptor, the product of the c-met protooncogene, and their role in embryogenesis.

摘要

许多涉及细胞迁移、生长或形态发生的发育过程都依赖于细胞外信号。一种提供此类信号的分子,即肝细胞生长因子/分散因子(HGF/SF),近年来因其独特的结构、激活机制以及在整个胚胎发育过程中的重要作用而备受关注。本文综述了HGF/SF及其受体(c-met原癌基因产物)的主要特征,以及它们在胚胎发育中的作用。

相似文献

1
Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase.肝细胞生长因子/散射因子(HGF/SF)及其受体c-Met酪氨酸激酶的发育作用
Trends Cell Biol. 1998 Oct;8(10):404-10. doi: 10.1016/s0962-8924(98)01359-2.
2
Hepatocyte growth factor as mitogen, motogen and morphogen, and its roles in organ regeneration.肝细胞生长因子作为促有丝分裂原、促运动因子和形态发生素及其在器官再生中的作用。
Princess Takamatsu Symp. 1994;24:195-213.
3
Expression of the met-receptor and its ligand, HGF-SF during mouse embryogenesis.在小鼠胚胎发育过程中,间质表皮转化因子受体(met受体)及其配体肝细胞生长因子-散射因子(HGF-SF)的表达。
EXS. 1993;65:381-94.
4
The hepatocyte growth factor/Met pathway in development, tumorigenesis, and B-cell differentiation.发育、肿瘤发生及B细胞分化过程中的肝细胞生长因子/Met信号通路
Adv Cancer Res. 2000;79:39-90. doi: 10.1016/s0065-230x(00)79002-6.
5
HGF/SF and its receptor c-MET play a minor role in the dissemination of human B-lymphoma cells in SCID mice.肝细胞生长因子/散射因子(HGF/SF)及其受体c-MET在人B淋巴瘤细胞在重症联合免疫缺陷(SCID)小鼠中的播散过程中起次要作用。
Br J Cancer. 1999 Sep;81(1):43-53. doi: 10.1038/sj.bjc.6690649.
6
Expression of the met receptor tyrosine kinase in muscle progenitor cells in somites and limbs is absent in Splotch mice.在斑点小鼠中,体节和四肢的肌肉祖细胞中met受体酪氨酸激酶不表达。
Development. 1996 Jul;122(7):2163-71. doi: 10.1242/dev.122.7.2163.
7
Roles of hepatocyte growth factor/scatter factor and the met receptor in the early development of the metanephros.肝细胞生长因子/分散因子及Met受体在后肾早期发育中的作用
J Cell Biol. 1995 Jan;128(1-2):171-84. doi: 10.1083/jcb.128.1.171.
8
Hepatocyte growth factor/scatter factor induces a variety of tissue-specific morphogenic programs in epithelial cells.肝细胞生长因子/分散因子可诱导上皮细胞中多种组织特异性形态发生程序。
J Cell Biol. 1995 Dec;131(6 Pt 1):1573-86. doi: 10.1083/jcb.131.6.1573.
9
Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo.肝细胞生长因子/散射因子(HGF/SF)的工程突变体,其与硫酸乙酰肝素蛋白聚糖的结合减少,体内清除率降低,活性增强。
Curr Biol. 1998 Jan 29;8(3):125-34. doi: 10.1016/s0960-9822(98)70059-4.
10
HGF: a multifunctional growth factor controlling cell scattering.肝细胞生长因子:一种控制细胞分散的多功能生长因子。
Int J Biochem Cell Biol. 1999 Dec;31(12):1357-62. doi: 10.1016/s1357-2725(99)00089-8.

引用本文的文献

1
Identification of c-Met on Tumor Cells as a Novel Receptor for B7-H3 Entails Implications for Cancer Cell Stemness and Targeted Therapy.肿瘤细胞上c-Met作为B7-H3的新型受体的鉴定对癌细胞干性和靶向治疗具有重要意义。
MedComm (2020). 2025 Aug 22;6(9):e70332. doi: 10.1002/mco2.70332. eCollection 2025 Sep.
2
A stable NTN1 fluorescent reporter chicken reveals cell specific molecular signatures during optic fissure closure.一种稳定的NTN1荧光报告基因鸡揭示了视神经裂闭合过程中的细胞特异性分子特征。
Sci Rep. 2025 Mar 24;15(1):10096. doi: 10.1038/s41598-025-94589-8.
3
Genome-wide CRISPR Screening Identifies NFκB and c-MET as Druggable Targets to Sensitize Lenvatinib Treatment in Hepatocellular Carcinoma.
全基因组CRISPR筛选确定NFκB和c-MET为可药物靶向,使肝癌对乐伐替尼治疗敏感。
Cell Mol Gastroenterol Hepatol. 2025;19(7):101502. doi: 10.1016/j.jcmgh.2025.101502. Epub 2025 Mar 20.
4
Evaluation of a Novel MET-Targeting Camelid-Derived Antibody in Head and Neck Cancer.新型靶向MET的骆驼科来源抗体在头颈癌中的评估。
Mol Pharm. 2024 Dec 2;21(12):6376-6384. doi: 10.1021/acs.molpharmaceut.4c00938. Epub 2024 Nov 8.
5
MET Oncogene Targeting for Cancer Immunotherapy.MET 癌基因靶向治疗用于癌症免疫治疗。
Int J Mol Sci. 2024 Jun 1;25(11):6109. doi: 10.3390/ijms25116109.
6
Genomic and Immune Landscape Comparison of MET Exon 14 Skipping and MET-Amplified Non-small Cell Lung Cancer.MET 外显子 14 跳跃和 MET 扩增型非小细胞肺癌的基因组和免疫景观比较。
Clin Lung Cancer. 2024 Sep;25(6):567-576.e1. doi: 10.1016/j.cllc.2024.05.001. Epub 2024 May 10.
7
p53 modulates kinase inhibitor resistance and lineage plasticity in NF1-related MPNSTs.p53调节NF1相关恶性外周神经鞘膜瘤中的激酶抑制剂抗性和谱系可塑性。
Oncogene. 2024 May;43(19):1411-1430. doi: 10.1038/s41388-024-03000-9. Epub 2024 Mar 13.
8
Development of an Engineered Single-Domain Antibody for Targeting MET in Non-Small Cell Lung Cancer.用于治疗非小细胞肺癌中 MET 的工程化单域抗体的开发。
Bioconjug Chem. 2024 Mar 20;35(3):389-399. doi: 10.1021/acs.bioconjchem.4c00019. Epub 2024 Mar 12.
9
Mfap4: a promising target for enhanced liver regeneration and chronic liver disease treatment.Mfap4:增强肝脏再生和治疗慢性肝病的一个有前景的靶点。
NPJ Regen Med. 2023 Nov 7;8(1):63. doi: 10.1038/s41536-023-00337-9.
10
Potential advantages of genetically modified mesenchymal stem cells in the treatment of acute and chronic liver diseases.基因修饰间充质干细胞在治疗急性和慢性肝病中的潜在优势。
Stem Cell Res Ther. 2023 May 24;14(1):138. doi: 10.1186/s13287-023-03364-x.